|
1
|
Skulsky SL, O'Sullivan B, McArdle O,
Leader M, Roche M, Conlon PJ and O'Neill JP: Review of high-risk
features of cutaneous squamous cell carcinoma and discrepancies
between the American Joint Committee on Cancer and NCCN clinical
practice guidelines in oncology. Head Neck. 39:578–594. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng J and Yan S: Prognostic variables in
high-risk cutaneous squamous cell carcinoma: A review. J Cutan
Pathol. 43:994–1004. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sherwood V and Leigh IM: WNT signaling in
cutaneous squamous cell carcinoma: A future treatment strategy? J
Invest Dermatol. 136:1760–1767. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu K, He Y, Xia C, Yan J, Hou J, Kong D,
Yang Y and Zheng G: MicroRNA-15a inhibits proliferation and induces
apoptosis in CNE1 nasopharyngeal carcinoma cells. Oncol Res.
24:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang G, Fu Y, Liu G, Ye Y and Zhang X:
miR-218 inhibits proliferation, migration, and EMT of gastric
cancer cells by targeting WASF3. Oncol Res. 25:355–364. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar
|
|
7
|
Liu X, Li J, Yu Z, Sun R and Kan Q:
MiR-935 promotes liver cancer cell proliferation and migration by
targeting SOX7. Oncol Res. 25:427–435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji S, Zhang B, Kong Y, Ma F and Hua Y:
MiR-326 inhibits gastric cancer cell growth through down regulating
NOB1. Oncol Res. 25:853–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou M, Zhou L, Zheng L, Guo L, Wang Y,
Liu H, Ou C and Ding Z: miR-365 promotes cutaneous squamous cell
carcinoma (CSCC) through targeting nuclear factor I/B (NFIB). PLoS
One. 9:e1006202014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu N, Zhang L, Meisgen F, Harada M,
Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E and Pivarcsi A:
MicroRNA-125b down-regulates matrix metallopeptidase 13 and
inhibits cutaneous squamous cell carcinoma cell proliferation,
migration, and invasion. J Biol Chem. 287:29899–29908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dotto GP and Karine L: miR-34a/SIRT6 in
squamous differentiation and cancer. Cell Cycle. 13:1055–1056.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding J, Cui X and Liu Q: Emerging role of
HMGB1 in lung diseases: Friend or foe. J Cell Mol Med.
21:1046–1057. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anggayasti WL, Mancera RL, Bottomley S and
Helmerhorst E: The self-association of HMGB1 and its possible role
in the binding to DNA and cell-membrane receptors. FEBS Lett.
591:282–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Y, Tu Y, He LI, Ji C and Cheng BO:
High mobility group box 1 regulates tumor metastasis in cutaneous
squamous cell carcinoma via the PI3K/AKT and MAPK signaling
pathways. Oncol Lett. 11:59–62. 2016.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma ZL, Hou PP, Li YL, Wang DT, Yuan TW,
Wei JL, Zhao BT, Lou JT, Zhao XT, Jin Y and Jin YX: MicroRNA-34a
inhibits the proliferation and promotes the apoptosis of non-small
cell lung cancer H1299 cell line by targeting TGFβR2. Tumour Biol.
36:2481–2490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu X, Zhong D, Gao Q, Zhai W, Ding Z and
Wu J: MicroRNA-34a inhibits human osteosarcoma proliferation by
downregulating ether à go-go 1 expression. Int J Med Sci.
10:676–682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ribeiro J, Marinho-Dias J, Monteiro P,
Loureiro J, Baldaque I, Medeiros R and Sousa H: miR-34a and
miR-125b expression in HPV infection and cervical cancer
development. Biomed Res Int. 2015:3045842015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chandrasekaran KS, Sathyanarayanan A and
Karunagaran D: Downregulation of HMGB1 by miR-34a is sufficient to
suppress proliferation, migration and invasion of human cervical
and colorectal cancer cells. Tumour Biol. 37:13155–13166. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pang X, Zhang Y and Zhang S: High-mobility
group box 1 is overexpressed in cervical carcinoma and promotes
cell invasion and migration in vitro. Oncol Rep. 37:831–840. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen M, Liu Y, Varley P, Chang Y, He XX,
Huang H, Tang D, Lotze MT, Lin J and Tsung A: High-mobility group
box 1 promotes hepatocellular carcinoma progression through
miR-21-mediated matrix metalloproteinase activity. Cancer Res.
75:1645–1656. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Ouyang M, Wang Q and Jian Z:
MicroRNA-142-3p inhibits hypoxia/reoxygenation-induced apoptosis
and fibrosis of cardiomyocytes by targeting high mobility group box
1. Int J Mol Med. 38:1377–1386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang ST, Wang F, Shao M, Wang Y and Zhu
HQ: MicroRNA-126 suppresses inflammation in endothelial cells under
hyperglycemic condition by targeting HMGB1. Vascul Pharmacol.
88:48–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Hu X, Xia D and Zhang S:
MicroRNA-181b is downregulated in non-small cell lung cancer and
inhibits cell motility by directly targeting HMGB1. Oncol Lett.
12:4181–4186. 2016.PubMed/NCBI
|
|
26
|
Gu J, Xu R, Li Y, Zhang J and Wang S:
MicroRNA-218 modulates activities of glioma cells by targeting
HMGB1. Am J Transl Res. 8:3780–3790. 2016.PubMed/NCBI
|
|
27
|
Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y,
Jia Y, Li Q, Zhang H, Tu K, et al: Methylation-mediated repression
of microRNA-129-2 suppresses cell aggressiveness by inhibiting high
mobility group box 1 in human hepatocellular carcinoma. Oncotarget.
7:36909–36923. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Chen L, Ding J, Fan Z, Li S, Wu H,
Zhang J, Yang C, Wang H, Zeng P and Yang J: MicroRNA-24 inhibits
high glucose-induced vascular smooth muscle cell proliferation and
migration by targeting HMGB1. Gene. 586:268–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu H, Huang L, Zhu S, Li X, Li Z, Yu C
and Yu X: Regulation of autophagy by systemic admission of
microRNA-141 to target HMGB1 in l-arginine-induced acute
pancreatitis in vivo. Pancreatology. 16:337–346. 2016. View Article : Google Scholar : PubMed/NCBI
|
